Somewhere in the deep recesses of our collective memory, the Concentration Ratio resides. It's a quick measure of how competitive an industry is. You can read all about it here. …
Good stuff... BIO recently published their latest report characterizing innovation in highly prevalent, chronic diseases. A full list of past reports is available here. They are short, data-rich, and quite…
Back during our early days as an Analyst with a venture capital fund, one of the Managing Partners always asked a simple question when assessing opportunities: "Will this change the…
Want to spend an entire decade surfing the web? Try finding and reading every article on “artificial intelligence.” A serious branch of computer science has rapidly turned into a buzzword…
Congrats on beginning your quest towards the Holiest of Grails in our industry...capital. Your Board has given you a "simple" mandate: Find an investor or a licensing partner for the…
The August Edition of Life Science Leader has a summary of a panel discussion. The article is available here, and is well worth the time to read it if you…
The good folks at Pharmaprojects just published their Pharma R&D Annual Review. A summary of the report, plus a link to the full report, is available here. The report…
Two months ago, it was reported that six US states filed lawsuits against Connecticut-based Purdue Pharma, accusing the company of “...fueling a national opioid epidemic by deceptively marketing its prescription painkillers...”…
At Lacerta Bio, we see a lot of financial models and valuations. Some of these are prepared internally, obviously. But many are prepared by management teams as part of…
Conferences like #BIO2018 are challenging, but highly rewarding experiences. This year was especially good, thanks to the record-setting crowd that attended the event in Boston. Conferences are a unique way…